BioLeaders' Series B - II Round

BioLeaders raised a round of funding on January 01, 2013. Investors include MG Investments.

BioLeaders (바이오리더스) (KOSDAQ: 142760) is a research-based, clinical stage biopharmaceutical company developing therapies that improve the lives of patients by inducing the body's innate and…

Articles about BioLeaders' Series B - II Round: